Search result for: Biologics

September 2026

Biologics and Biosimilars Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8097
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.

September 2026

Biologics CDMO Market Size, Key Companies, Company Production Capacity, Healthcare Infrastructure Growth, Product Utilization, Regulatory Compliance, Company Expansion Strategies, Company Investment Strategies, and Market Outlook

  • Report Code : 4943
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics CDMO market size was valued at USD 25.08 billion in 2026 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.

August 2026

Biologics Market Size, Key Companies, Company Product Portfolio, Hospital Procurement Trends, Manufacturing Capacity, Sales Performance, Regulatory Approvals, Company Market Share, and Forecast

  • Report Code : 1638
  • Published : August 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics market was valued at USD 487 billion in 2025 and is expected to hit around USD 1243.80 billion by 2035, growing at a CAGR of 9.83%.

August 2025

Biologics Contract Development Market Driving Innovation and Future Growth

  • Report Code : 3056
  • Published : August 2025
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global biologics contract development market size reached USD 8.18 billion in 2024 and is projected to hit around USD 23.01 billion by 2034 with a solid CAGR of 10.89%.

September 2026

Next-Generation Biologics Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 6397
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global next-generation biologics market size was evaluated at USD 135.12 billion in 2026 and is predicted to hit around USD 301.22 billion by 2034, growing at a CAGR of 10.54% from 2025 to 2034.

September 2026

U.S. Biologics Market Size, Companies, Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 8457
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The U.S. biologics market was worth USD 223.60 billion in 2026, with key U.S. biologics market players including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche.

September 2026

Wound Care Biologics Market Size, Key Companies, Company Market Share, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Competitive Positioning, and Demand Forecast

  • Report Code : 3921
  • Published : September 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The wound care biologics market size is expected to surpass around USD 11.22 billion by 2034, increasing from USD 6.65 billion in 2026, with a CAGR of 6.75%

July 2026

Orthobiologics Market Size, Share and Trends 2026 to 2035

  • Report Code : 4755
  • Published : July 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The orthobiologics market size was estimated at USD 7.37 billion in 2025 and is expected to surge around USD 12.55 billion by 2035, with a notable CAGR of 5.47%.

June 2026

Checkpoint Inhibitor Biologics CDMO Market Size, Share and Trends 2026 to 2035

  • Report Code : 6981
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.

June 2026

Neurological Rare Disease Biologics Market Size, Share and Trends 2026 to 2035

  • Report Code : 6787
  • Published : June 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.

March 2026

Cancer Biologics Market Size, Share and Trends 2026 to 2035

  • Report Code : 4005
  • Published : March 2026
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The global cancer biologics market size was valued at USD 117.45 billion in 2025 and is expected to hit around USD 235.81 billion by 2035 with a CAGR of 7.22%.

July 2025

Anti-Inflammatory Biologics Market Poised for Growth Amid Rising Chronic Conditions

  • Report Code : 4507
  • Published : July 2025
  • Delivery : Immediate
  • Category : Healthcare
  • No. of Pages : 150+

The anti-Inflammatory biologics market size reached USD 104.81 billion in 2024 and is projected to surpass around USD 185.51 billion by 2034 with a notable CAGR of 5.88%.

For Any Query

Please drop a mail to the Precedence Research team for your queries

Contact Us

Categories

Quick Contact

call +1 650 460 3308 call +61 485 981 310
+91 87933 22019 call +44 7383 092 044 mail sales@precedenceresearch.com

Connect with us now; your solution awaits on the other side!

Contact Us